Children born to mothers with pregnancy-related diabetes run twice the risk of language development problems, according to a research team
Read More »Diabetes Plus Hypertension Increases Risk for Poor Diet
People with diabetes and hypertension are less likely to comply with nutritional recommendations for lowering blood pressure than people with hypertension alone, reported at the American Public Health Association 136th Annual Meeting.
Read More »Diabetic Athlete’s Handbook: Your guide to peak performance
Sheri Colberg Ph.D. has written a new book based on her experiences as an athlete and diabetes patient. The Diabetic Athlete’s Handbook: Your guide to peak performance is reviewed this week by Shannon Hart, PharmD Candidate University of Florida College of Pharmacy
Read More »Gastric Bypass For Older Type 2’s? Till What Age?
Recent studies showing that gastric bypass surgery extends the lives of obese patients is forcing surgeons to make tough decisions about who should go under the knife and who shouldn’t.
Read More »Research Finds Three-Quarters of Youths With Diabetes Insufficient In Vitamin D
Study urges supplementation of vitamin D to protect bones later in life for those children found to be deficient in vitamin D (75%).
Read More »Diabetes Linked To Risk Of Lymphoma
More cases of blood cancers classified as non-Hodgkin’s lymphoma, or NHL, seem to occur among people with diabetes than those without, researchers report.
Read More »Sleep Apnea Treatment Reduces Nighttime Blood Sugar
Patients with type 2 diabetes and obstructive sleep apnea who used continuous positive airway pressure (CPAP) saw improved glycemic control during the night.
Read More »Psoriasis, Metabolic Syndrome Linked to High Leptin Levels
Psoriasis and metabolic syndrome both are associated with high serum levels of leptin, according to a new report. “Body weight loss could potentially become part of the general treatment of psoriasis, especially in patients with obesity.”
Read More »Next DPP-4 inhibitor (Alogliptin) Found Safe and Effective in Poorly Controlled Type 2’s
Therapy with alogliptin alone is significantly reduced glycosylated hemoglobin A1c levels in patients with type 2 diabetes and inadequate glycemic control, according to a double-blind, placebo-controlled, multicenter trial reported this month.
Read More »Atorvastatin, Fenofibrate Fixed Combo Is Effective For Mixed Dyslipidemia
A once-daily, fixed-dose tablet combining atorvastatin and a novel micronized formulation of fenofibrate outperformed either drug alone in a phase II clinical trial in patients with mixed dyslipidemia.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.